This Clinical Statement was developed by TB and Ophthalmic specialists to improve and standardise patient care and support those managing patients with this disease, whether confirmed or suspected. The Clinical Statement outlines the current understanding of disease pathogenesis, diagnosis and management in adults, and also provides consensus points with the currently available data and best practices that can be applied in clinics.
Join international Pulmonary Embolism (PE) expert Professor Stavros Konstantinides as he discusses...
Interstitial Lung Disease (ILD) is an umbrella term for lung disorders characterised by tissue...
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...